Logo image of MORE.AS

MOREFIELD GROUP NV (MORE.AS) Stock Fundamental Analysis

AMS:MORE - Euronext Amsterdam - CWN814651014 - Common Stock - Currency: EUR

0.51  +0.01 (+0.99%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MORE. MORE was compared to 30 industry peers in the Professional Services industry. There are concerns on the financial health of MORE while its profitability can be described as average. MORE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MORE had positive earnings in the past year.
MORE had a positive operating cash flow in the past year.
MORE had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MORE reported negative operating cash flow in multiple years.
MORE.AS Yearly Net Income VS EBIT VS OCF VS FCFMORE.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

1.2 Ratios

MORE has a better Return On Assets (9.16%) than 72.41% of its industry peers.
With a decent Return On Equity value of 30.76%, MORE is doing good in the industry, outperforming 79.31% of the companies in the same industry.
MORE's Return On Invested Capital of 23.73% is amongst the best of the industry. MORE outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 9.16%
ROE 30.76%
ROIC 23.73%
ROA(3y)8.21%
ROA(5y)-27.58%
ROE(3y)21.06%
ROE(5y)-237.26%
ROIC(3y)N/A
ROIC(5y)N/A
MORE.AS Yearly ROA, ROE, ROICMORE.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M 2M 3M

1.3 Margins

Looking at the Profit Margin, with a value of 5.82%, MORE is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
MORE has a better Operating Margin (10.84%) than 75.86% of its industry peers.
Looking at the Gross Margin, with a value of 56.66%, MORE is in line with its industry, outperforming 55.17% of the companies in the same industry.
Industry RankSector Rank
OM 10.84%
PM (TTM) 5.82%
GM 56.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MORE.AS Yearly Profit, Operating, Gross MarginsMORE.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

MORE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MORE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, MORE has more shares outstanding
Compared to 1 year ago, MORE has an improved debt to assets ratio.
MORE.AS Yearly Shares OutstandingMORE.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
MORE.AS Yearly Total Debt VS Total AssetsMORE.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

MORE has an Altman-Z score of 1.59. This is a bad value and indicates that MORE is not financially healthy and even has some risk of bankruptcy.
MORE has a worse Altman-Z score (1.59) than 72.41% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that MORE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.75, MORE perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACC3.85
WACC6.16%
MORE.AS Yearly LT Debt VS Equity VS FCFMORE.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

MORE has a Current Ratio of 0.99. This is a bad value and indicates that MORE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MORE (0.99) is comparable to the rest of the industry.
A Quick Ratio of 0.72 indicates that MORE may have some problems paying its short term obligations.
MORE has a worse Quick ratio (0.72) than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.72
MORE.AS Yearly Current Assets VS Current LiabilitesMORE.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

MORE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.17%.
Measured over the past years, MORE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -49.09% on average per year.
MORE shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.06%.
EPS 1Y (TTM)-26.17%
EPS 3Y356.29%
EPS 5Y-49.09%
EPS Q2Q%-51.77%
Revenue 1Y (TTM)73.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MORE.AS Yearly Revenue VS EstimatesMORE.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
MORE.AS Yearly EPS VS EstimatesMORE.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.67 indicates a rather cheap valuation of MORE.
Based on the Price/Earnings ratio, MORE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MORE to the average of the S&P500 Index (29.35), we can say MORE is valued rather cheaply.
Industry RankSector Rank
PE 5.67
Fwd PE N/A
MORE.AS Price Earnings VS Forward Price EarningsMORE.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MORE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MORE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.7
MORE.AS Per share dataMORE.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MORE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOREFIELD GROUP NV

AMS:MORE (3/7/2025, 7:00:00 PM)

0.51

+0.01 (+0.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners16.29%
Ins Owner ChangeN/A
Market Cap5.53M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.67
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF 0.48
P/B 0.29
P/tB 0.36
EV/EBITDA 0.7
EPS(TTM)0.09
EY17.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)1.06
OCFY207.43%
SpS9.31
BVpS1.76
TBVpS1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.16%
ROE 30.76%
ROCE 31.44%
ROIC 23.73%
ROICexc 27.76%
ROICexgc 31.66%
OM 10.84%
PM (TTM) 5.82%
GM 56.66%
FCFM N/A
ROA(3y)8.21%
ROA(5y)-27.58%
ROE(3y)21.06%
ROE(5y)-237.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Debt/EBITDA 0.73
Cap/Depr 157.63%
Cap/Sales 13.57%
Interest Coverage 250
Cash Conversion 58.41%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.72
Altman-Z 1.59
F-Score7
WACC6.16%
ROIC/WACC3.85
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.17%
EPS 3Y356.29%
EPS 5Y-49.09%
EPS Q2Q%-51.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)73.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1987.85%
FCF growth 3YN/A
FCF growth 5Y-27.13%
OCF growth 1Y10827.1%
OCF growth 3YN/A
OCF growth 5Y-5.75%